Stock data

健喬 (4114)

健喬 is a TPEx-listed company in Biotech & Medical Care. Revenue for September 2026 was NT$746.97M, up 38.7% from a year earlier. EPS over the last four quarters totals NT$1.59.

Charts, drawing tools, and the P/E calculator are in the app, free to use.

Open 健喬 in Insightr